Search results :

Auranofin

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: M01CB03

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2
Diarrhoea Diarrhoea postmarketing, 13% - 47% x x
Loose stools x x
Dermatitis Rash postmarketing, 24% - 39% x x
Rash Rash postmarketing, 24% - 39% x x
Pruritus Pruritus 17% x x
Abdominal pain Abdominal pain 14% x x
Gastrointestinal pain Abdominal pain 14% x x
Stomatitis Stomatitis postmarketing, 13% - 18% x x
Vomiting Vomiting 10% x x
Proteinuria Proteinuria postmarketing, 0.9% - 5.4% x x
Protein urine present Proteinuria postmarketing, 0.9% - 5.4% x x
Anaemia Anaemia postmarketing, 1.6% - 3.1% x x
Leukopenia Leukopenia postmarketing, 1.3% - 2.2% x x
Thrombocytopenia Thrombocytopenia postmarketing, 0.9% - 2.2% x x
Agranulocytosis Agranulocytosis 0.1% x x
Aplastic anaemia Aplastic anaemia 0.1% x x
Angioedema Angioedema 0.1% x x
Dysphagia Dysphagia 0.1% x x
Dermatitis exfoliative Dermatitis exfoliative postmarketing x
Glomerulonephritis membranous Glomerulonephritis membranous 0.1% x
Jaundice Jaundice 0.1% x x
Nephrotic syndrome Nephrotic syndrome 0.1% x
Neuropathy peripheral Neuropathy peripheral 0.1% x x
Colitis ulcerative Ulcerative enterocolitis 0.1% x x
Interstitial lung disease Interstitial pneumonia 0.1% x x
Alopecia Alopecia x x
Decreased appetite Anorexia x x
Conjunctivitis Conjunctivitis x x
Constipation Constipation x x
Dysgeusia Dysgeusia x x
Dyspepsia Dyspepsia x
Eosinophilia Eosinophilia x x
Eye disorder Eye disorder x
Flatulence Flatulence x x
Gastrointestinal haemorrhage Gastrointestinal haemorrhage x x
Gingivitis Gingivitis x x
Glossitis Glossitis x x
Haematuria Haematuria x x
Melaena Melaena x x
Nausea Nausea x x
Neutropenia Neutropenia x x
Pancytopenia Pancytopenia x
Aplasia pure red cell Aplasia pure red cell x
Urticaria Urticaria x x
Weight decreased Weight decreased x
Hepatic enzyme increased Hepatic enzyme increased x x
Visual impairment Visual impairment x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

AURANOFIN / RIDAURA

Side effects:38
Source:Health Canada

auranofin

Side effects:41
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label